Results 171 to 180 of about 42,994 (252)
Metformin at the Time of COVID‐19 Infection and Risk of Long COVID: A Target Trial Emulation Study
ABSTRACT Our objective was to evaluate metformin prescribed at the time of SARS‐CoV‐2 infection on the risk of developing Long COVID (LC) in electronic health record data. We conducted a new user analysis of metformin prescribed within 6 days of documented infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) versus experimental ...
Carolyn T. Bramante +15 more
wiley +1 more source
[Progress and controversies in prediabetes. Is a more holistic approach needed?] [PDF]
Apiñaniz Fernández de Larrinoa A +1 more
europepmc +1 more source
ABSTRACT This study explored the association between the composite dietary antioxidant index (CDAI) and cardiovascular‐kidney‐metabolic (CKM) progression in an older population. Using data from NHANES 2001–2020, we analyzed 4974 adults aged ≥ 60 years with CKM syndrome. The CDAI was calculated from the intake of six dietary antioxidants.
Fu‐Shan Qiu +3 more
wiley +1 more source
Understanding How to Make Type 2 Diabetes Prevention Programs More Inclusive: An Equity-Oriented Qualitative Case Study of Small Steps for Big Changes. [PDF]
Der S, Cranston K, Jung M.
europepmc +1 more source
ABSTRACT Studies have shown that omega‐3 fatty acids may protect against cardiovascular diseases (CVDs) and related metabolic conditions. UK Biobank is a large cohort study that includes data on plasma omega‐3 fatty acids at study entry and health outcomes during the follow‐up period.
Warda Tul Firdous, Philip C. Calder
wiley +1 more source
Differential Associations of Healthy Lifestyle Latent Classes with Glycemic Transitions in Prediabetes: An Observational Study Based on CHARLS. [PDF]
Ma M +5 more
europepmc +1 more source
ABSTRACT Objective SURMOUNT‐REAL UK will evaluate the effectiveness of tirzepatide when offered in addition to standard‐of‐care (SoC) in adults with Class I obesity (BMI ≥ 30 and ≤ 34.9 kg/m2) and without diabetes in a UK primary care setting. Methods A 5‐year, phase 4, multicenter, open‐label, pragmatic randomized clinical trial is enabled through ...
Martin K. Rutter +14 more
wiley +1 more source
The Role of SGLT2 Inhibitors in the Prevention of Type 2 Diabetes: A Narrative Review of Current Evidence. [PDF]
Owczarczyk-Durma AC +2 more
europepmc +1 more source

